Goldinger, SM; Gobbi, S; Ding, M; Frauchiger, AL; Fink-Puches, R; Klemke, CD; Dreno, B; Bagot, M; Assaf, C; Dummer, R..
A multicenter, open label, phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma.
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
[Poster]
Web of Science